---
title: "最新发布！中国食管癌放射治疗指南 (2025版)：颈段食管癌放疗剂量推荐有更新"
date: 2026-01-21T05:02:16Z
draft: ["false"]
tags: [
  "fetched",
  "放疗说"
]
categories: ["Acdemic"]
---
最新发布！中国食管癌放射治疗指南 (2025版)：颈段食管癌放疗剂量推荐有更新 by 放疗说
------
<div><section><span><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_gif/cZkI8M0nbCnqFdBSZTPngyO5KHUZhk4AxVnD35ghok0OeZwg6P9VmU0ysfVMGUQe0QHlvzvYQQTWLvPnN5XibCw/640?wx_fmt=gif&amp;wxfrom=5&amp;wx_lazy=1" data-ratio="1" data-type="gif" data-w="400" data-imgfileid="100041008" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_gif/cZkI8M0nbCnqFdBSZTPngyO5KHUZhk4AxVnD35ghok0OeZwg6P9VmU0ysfVMGUQe0QHlvzvYQQTWLvPnN5XibCw/640?wx_fmt=gif&amp;wxfrom=5&amp;wx_lazy=1"></span><span><span leaf="">点蓝</span></span><span leaf="">色字</span></span><span><span leaf="">关注</span></span><span><strong><span><span leaf="">“放疗说”</span></span></strong></span><span><strong><span></span></strong></span><span leaf=""><br></span></section><section data-role="paragraph"><section data-tools="135编辑器"><section label="Edit by 135editor.com" data-role="outer" data-tools="135编辑器"><section data-tools="135编辑器"><section><span><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd5r3MALt2DtsQHicIDV6J82QrkiceYSbC7Sdt0hU0HWXBcAUBS8BfK9fnTX2u6e83UrqJTKYrBZRGicw/640?wx_fmt=png&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-ratio="1" data-type="png" data-w="968" data-imgfileid="100041009" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd5r3MALt2DtsQHicIDV6J82QrkiceYSbC7Sdt0hU0HWXBcAUBS8BfK9fnTX2u6e83UrqJTKYrBZRGicw/640?wx_fmt=png&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></span></span></section><section><p><strong><span leaf="">放疗说</span></strong></p><p><span leaf="">专业科普，学术交流，记录不断进步的放疗行业。</span></p></section><section><span leaf=""><a target="_blank" href="https://mp.weixin.qq.com/s?__biz=Mzk0MzIxOTcwMQ==&amp;mid=2247507870&amp;idx=1&amp;sn=56aac0cd57d874abe18ac2e1ddcd7a94&amp;scene=21#wechat_redirect" textvalue="" linktype="text" data-linktype="2">all</a></span></section></section></section></section></section><p><span leaf=""><br></span></p><p><span><span leaf="">2026年1月17日，</span><span><span leaf="">中华医学会放射肿瘤治疗学分会/</span><span><span leaf="">中国医师协会放射肿瘤治疗医师分会/</span></span><span leaf="">中国抗癌协会肿瘤放射治疗专业委员会重磅发布</span></span><span leaf="">《中国食管癌放射治疗指南（2025年版）》！</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">本版指南执笔专家组组长为山东省肿瘤医院</span><strong><span leaf="">李宝生</span></strong><span leaf="">教授，副组长分别为天津医科大学肿瘤医院</span><strong><span><span leaf="">王平</span></span></strong><span><span leaf="">教授</span></span><span leaf="">、重庆大学附属肿瘤医院</span><strong><span><span leaf="">吴永忠</span></span></strong><span><span leaf="">教授以及</span><span data-pm-slice='2 2 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0px;margin-left: 16px;outline: 0px;letter-spacing: 0.544px;text-wrap: wrap;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span leaf="">河北医科大学第四医院</span><strong><span leaf="">王军</span></strong><span leaf="">教授。</span><span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0em;margin-left: 16px;outline: 0px;max-width: 100%;color: rgb(34, 34, 34);letter-spacing: 0.544px;white-space: normal;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"color: rgb(62, 62, 62);font-family: PingFangSC-Light;font-size: 14px;letter-spacing: 1px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><br></span></span></span></span></span></p><p><span><span><span data-pm-slice='2 2 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0px;margin-left: 16px;outline: 0px;letter-spacing: 0.544px;text-wrap: wrap;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0em;margin-left: 16px;outline: 0px;max-width: 100%;color: rgb(34, 34, 34);letter-spacing: 0.544px;white-space: normal;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"color: rgb(62, 62, 62);font-family: PingFangSC-Light;font-size: 14px;letter-spacing: 1px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><br></span></span></span></span></span></p><p><span><span><span data-pm-slice='2 2 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0px;margin-left: 16px;outline: 0px;letter-spacing: 0.544px;text-wrap: wrap;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0em;margin-left: 16px;outline: 0px;max-width: 100%;color: rgb(34, 34, 34);letter-spacing: 0.544px;white-space: normal;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"color: rgb(62, 62, 62);font-family: PingFangSC-Light;font-size: 14px;letter-spacing: 1px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'>与2024版相比，2025版指南进一步强化了放疗在食管癌多学科治疗中的核心定位，细化了不同分期、不同治疗目标下的放疗策略，在关键技术环节提出了更明确的推荐。同时，系统规范了放疗与免疫治疗的联合应用，回应临床热点，为改善患者长期预后提供了重要指导。</span></span></span></span></span></p><p><span><span><span leaf=""><br></span></span></span></p><p><span><span leaf="">本文与大家共同学习新版指南对于食管癌放射治疗原则的完整推荐，仅供参考学习。</span></span></p><p><span><span leaf=""><br></span></span></p><section data-role="paragraph"><section data-tools="135编辑器" data-id="92663" data-width="98%"><section><section data-width="100%"><section><section data-width="100%"><section><span leaf=""><br></span></section></section></section><section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd7tXwsMw511ff7aqoFVFGUtpraJQ5KgtnFhsgJpicpDrHDKz2DbPb5Jn0ueCn42ffibnZfXgQuum5jA/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.9943181818181818" data-type="jpeg" data-w="528" title="src=http___www.wenkusou.com_UploadFiles_img_2_1140892456_1381202386_26.jpg&amp;refer=http___www.wenkusou.jpg" data-width="100%" data-cropselx1="0" data-cropselx2="210" data-cropsely1="0" data-cropsely2="210" data-imgfileid="100041011" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd7tXwsMw511ff7aqoFVFGUtpraJQ5KgtnFhsgJpicpDrHDKz2DbPb5Jn0ueCn42ffibnZfXgQuum5jA/640?wx_fmt=png&amp;from=appmsg"></section></section><section><p><span><strong><span><span leaf="">李宝生 教授</span></span></strong></span></p><section><span><span leaf="">山东省肿瘤医院</span></span></section><p><span leaf=""><br></span></p></section></section></section></section><section data-role="outer" label="Powered by 135editor.com"><p><span><span leaf="">| 博士、博士生导师、泰山学者特聘专家；山东一医大临床与基础医学院副院长、全国重点实验室副主任</span></span></p><p><span><span leaf="">| 中国医师协会肿瘤放射治疗医师分会荣誉会长、中华医学会肿瘤放射治疗学分会候任主委、中国抗癌协会肿瘤放射治疗分会副主任委员、山东省医学会肺癌食管癌多学科联合委员会主席、山东省医学会肿瘤学分会候任主任委员、山东省医师协会肿瘤放疗医师分会主任委员、北方肿瘤放射治疗协作组主席、《国际肿瘤学杂志》总编辑、《中华肿瘤防治杂志》副总编</span></span></p></section></section><p><span></span></p><p><span></span></p><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><strong><span leaf="">1</span></strong></section><section><section data-brushtype="text" hm_fix="350:507"><span leaf="">放疗适应证与禁忌证</span></section></section></section></section></section><section data-role="splitline" data-tools="135编辑器" data-id="103122"><section><span leaf=""><br></span></section><section><span leaf=""><br></span></section></section><p><span><span leaf="">食管癌放射治疗的适应证与禁忌证推荐如下：</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><strong><span><span leaf="">1. 适应证</span></span></strong></span></p><p><span><strong><span><span leaf=""><br></span></span></strong></span></p><section data-role="paragraph"><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><section data-tools="135编辑器" data-id="106900" data-width="100%"><section><section><section data-width="100%" nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd7tXwsMw511ff7aqoFVFGUt4eHicqrqaUSxGS0lAnic1XsdzFYFhT1oGQ1Riamz7Mp5bMiaKk6yecVjVQ/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.6345565749235474" data-s="300,640" data-type="png" data-w="654" data-imgfileid="100041076" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd7tXwsMw511ff7aqoFVFGUt4eHicqrqaUSxGS0lAnic1XsdzFYFhT1oGQ1Riamz7Mp5bMiaKk6yecVjVQ/640?wx_fmt=png&amp;from=appmsg"></section><section data-autoskip="1"><p><span><span leaf="">▲食管癌患者放疗适应证（与2024版食管癌放射治疗指南一致）</span></span></p></section></section></section></section></section></section></section></section><p><span><strong><span><span leaf="">2. 禁忌证或相对禁忌证</span></span></strong></span></p><section data-role="paragraph" data-width="100%"><section><section><section><section><section><section data-role="paragraph"><p><span leaf=""><br></span></p></section></section></section></section></section></section></section><section data-role="paragraph"><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><section data-tools="135编辑器" data-id="106900" data-width="100%"><section><section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd7tXwsMw511ff7aqoFVFGUtOjPBTOrmGqicsd4pq9nUdDYRJwJyKHB1bql4UDJ2ic5DPgRibIWiaricPibQ/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.3128834355828221" data-s="300,640" data-type="png" data-w="652" data-imgfileid="100041077" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd7tXwsMw511ff7aqoFVFGUtOjPBTOrmGqicsd4pq9nUdDYRJwJyKHB1bql4UDJ2ic5DPgRibIWiaricPibQ/640?wx_fmt=png&amp;from=appmsg"></section><section data-autoskip="1"><p><span><span leaf="">▲食管癌患者放疗禁忌证或相对禁忌证（</span><span><span leaf="">与2024版食管癌放射治疗指南一致</span></span><span leaf="">）</span></span></p></section></section></section></section></section></section></section></section></section></section><p><span leaf=""><br></span></p><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><strong><span leaf="">2</span></strong></section><section><section data-brushtype="text" hm_fix="350:507"><span leaf="">定位技术规范</span></section></section></section></section></section><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><p><span><strong><span><span leaf="">1. 食管癌CT模拟定位</span></span></strong></span></p><p><span><span leaf=""><br></span></span><span><span leaf="">通常情况下，为避免造影剂可能导致的恶心、呕吐，定位前患者需空腹。需照射腹部时，则建议定位前及每次放疗前 15min 空腹服用清水或半流质饮食（粥、酸奶等）200ml。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">患者仰卧位，根据病变所在段别，采用头颈肩热塑面膜、体膜、真空负压袋、发泡胶等进行体位固定，也可多种技术配合以提高体位可重复性和患者舒适度。双臂平行置于体侧（在射野不穿过双臂的情况下，但可能限制部分射野角度），亦可双手抱肘置于前额，双腿自然并拢，全身放松。</span></span></p><p><span><span leaf=""><br></span></span></p><p><strong><span><span leaf="">CT扫描方式为螺旋扫描，层厚一般为 3mm</span></span></strong><span><span leaf="">，扫描范围根据病变部位、范围设定，但必须包全双侧颈部锁骨上、双肺。为了对呼吸运动进行管理，可以在进行CT扫描时配合主动呼吸控制、四维CT、呼吸门控等运动管理技术。颈段、胸上段食管癌标记点推荐放于下颌，胸中、下段食管癌标记点放于胸部较平坦部位，为了提高摆位准确性推荐增加盆腔摆位十字，以减少左右方向或躯干旋转导致的误差。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">增强扫描（碘过敏者也可平扫或MRI扫描）时一般设置碘对比剂流速为 2ml/s，总剂量 92ml，延迟时间为 50s。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><strong><span><span leaf="">2. 食管癌MRI模拟定位</span></span></strong></span></p><p><span><span leaf=""><br></span></span><span><span leaf="">需与CT模拟定位时的固定方式、体位完全一致，横断位层厚 3mm，同时避免线圈与身体接触。MRI扫描序列包括T1WI平扫、钆对比剂注射 15s 和 120s 延迟T1WI增强、FS-T2WI、DWI序列及600 s延迟T1WI增强序列。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><strong><span><span leaf="">3. 质子、重离子放疗定位</span></span></strong></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">基本原则、体位固定方式与光子放疗相同。</span><strong><span leaf="">但质子放疗模拟定位还应注意以下内容：</span></strong></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">1）基于能谱CT获得的电子密度图和原子序数图，可以重建得到阻止本领比（stopping power ratio，SPR）图像，以此进行粒子剂量计算可进一步缩小基于常规CT计算带来的射程不确定性，故建议选择能谱CT进行质子放疗模拟定位；以平扫CT进行质子剂量计算；</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">2）能谱CT生成的虚拟平扫CT图像在骨组织结构区域的HU值与真实平扫的HU值有显著差异，会影响质子剂量计算精度，应进行校正后使用；</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">3）CT扫描范围应完全覆盖体位固定后的患者，且治疗床和固定装置均应包含其中；</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">4）</span></span><span><span leaf="">扫描野需包含可能位于射野路径上的所有材料；</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">5）注意CT伪影和造影剂伪影，应尽量减少或对其进行修正；因质子束的射程不确定性，患者体位固定装置应最少化且易区分；</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">6）被质子束投射的固定装置应尽量薄，以最小化侧向半影，从而保持较好的剂量适形度和侧向器官保护。</span></span></p><p><span><span leaf=""><br></span></span></p><p><strong><span><span leaf="">首程放疗后的复位一般在40~50Gy左右时。</span></span></strong></p><p><strong><span><span leaf=""><br></span></span></strong></p><p><span leaf=""><br></span></p><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><strong><span leaf="">3</span></strong></section><section><section data-brushtype="text" hm_fix="350:507"><span leaf="">食管癌根治性放（化）疗靶区定义</span></section></section></section></section></section><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><p><span><span leaf=""><span textstyle="">大体肿瘤靶区（GTV）：</span>包括原发肿瘤（GTVp）及转移淋巴结（GTVn）。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">GTVp为可见的食管病灶，应综</span></span><span><span leaf="">合多种影像学</span></span><span><span leaf="">[食管造影、增强CT、MRI和（或）PET-CT]</span></span><span><span leaf="">和内镜</span></span><span><span leaf="">[电子上消化道内镜和（或）腔内超声]</span></span><span><span leaf="">结果确定。</span></span></p><p><span leaf=""><br></span></p><p><span><span leaf="">GTVn为可见的转移淋巴结，指CT、超声和（或）MRI显示的短径≥10mm（食管旁、气管食管沟 ≥5mm）的淋巴结，或PET-CT显示标准摄取值（SUV）高（炎性淋巴结除外），或者虽低于上述标准，但淋巴结有明显坏死、环形强化、强化程度与原发灶相仿、偏心钙化者，也作为GTVn。</span></span></p><p><span><span leaf=""><br></span></span></p><p><strong><span><span leaf=""><span textstyle="">临床靶区（CTV）：根治性放化疗推荐累及野照射。</span></span><span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0em;margin-left: 16px;outline: 0px;max-width: 100%;color: rgb(34, 34, 34);letter-spacing: 0.544px;white-space: normal;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"color: rgb(62, 62, 62);font-family: PingFangSC-Light;font-size: 14px;letter-spacing: 1px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span textstyle="">累及野照射时，CTVp定义为GTVp前后、左右方向均外放 5~6mm，上下方向各外放 30mm；CTVn定义为GTVn所在的淋巴结区（外放后将解剖屏障包括在内时需做调整）。</span></span></span></span><span><span leaf=""><br></span></span></strong></p><p><span leaf=""><br></span></p><p><span><span leaf=""><span textstyle="">注：</span></span><span leaf=""><span textstyle="">基于NROG-001研究结果，在2024版指南做出改变的基础上，2025版进一步对根治性放疗靶区推荐累及野照射</span><span textstyle="">。</span></span><span leaf=""><br></span></span></p><p><span><span leaf=""><br></span></span><span><span leaf="">选择性淋巴结照射时，除食管原发病灶和转移淋巴结区外，尚需包括淋巴结转移率较高的相应淋巴引流区域，以下可供参考（淋巴结引流区分组参照日本JES 12th标准）。</span></span></p><p><span><span leaf=""><br></span></span></p><ul><li><p><span><span leaf="">颈段：双侧101、双侧102、双侧104、105、106rec；</span></span></p></li><li><p><span><span leaf="">胸上段：双侧101、双侧104、105、106、部分108组；</span></span></p></li><li><p><span><span leaf="">胸中段：双侧101、双侧104、105、106、107、108、部分110、腹部1、2、3、7组；</span></span></p></li><li><p><span><span leaf="">胸下段：107、108、110、腹部1、2、3、7组；</span></span></p></li><li><p><span><span leaf="">上段跨中段：双侧101、双侧104、105、106、107、108组；</span></span></p></li><li><p><span><span leaf="">中段跨上段：105、106、107、108、部分110组；</span></span></p></li><li><p><span><span leaf="">中段跨下段：部分105、部分106、107、108、110、腹部1、2、3、7组；</span></span></p></li><li><p><span><span leaf="">下段跨中段：107、108、110、腹部1、2、3、7组。</span></span></p></li></ul><p><span><span leaf=""><br></span></span></p><p><span><span leaf=""><span textstyle="">内靶区（ITV）：</span>根据四维CT等测定肿瘤运动情况而确定。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf=""><span textstyle="">计划靶区（PTV）：</span>在ITV（CTV）各方向外放 5mm，纵向外放可至 8mm（实际外放根据各中心质控数据自行决定）。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">一般选择性淋巴结照射首程给予预防剂量之后需重复定位。若无新发病灶，则后续仅做累及野照射，至根治量。目前研究证明临床N0期患者从选择性淋巴结照射获益更多。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf=""><br></span></span></p><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><strong><span leaf="">4</span></strong></section><section><section data-brushtype="text" hm_fix="350:507"><span leaf="">食管癌新辅助放（化）疗靶区定义</span></section></section></section></section></section><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><p><strong><span><span leaf="">目前国际上尚无专门针对食管癌新辅助放化疗的放疗靶区规定</span></span></strong><span><span leaf="">，建议依据根治性放疗累及野照射原则。勾画靶区时需考虑后续手术切除时吻合口的位置，应尽量避免吻合口位于照射野内，从而降低吻合口瘘发生率。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span leaf=""><br></span></p><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><strong><span leaf="">5</span></strong></section><section><section data-brushtype="text" hm_fix="350:507"><span leaf="">食管癌术后放疗靶区定义</span></section></section></section></section></section><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><p><span><span leaf="">NCCN指南不推荐食管鳞癌根治术后R0切除患者辅助治疗，但根据国际上特别是国内大宗病例报道的复发率、前瞻性分层研究和大样本病例的回顾性分析结果，</span></span><strong><span><span leaf="">对于淋巴结阳性和（或）pT</span></span><span><span leaf="">3-4a</span></span><span><span leaf="">N</span></span><span><span leaf="">0</span></span><span><span leaf="">期食管癌推荐行术后放疗或放化疗，高危pT</span></span><span><span leaf="">2</span></span><span><span leaf="">N</span></span><span><span leaf="">0</span></span><span><span leaf="">期腺癌推荐术后化疗。</span></span></strong></p><p><span><span leaf=""><br></span></span></p><p><strong><span><span leaf="">术后放疗CTV：</span></span></strong><span><span leaf="">双侧锁骨上区及上纵隔区，即104、105、106、107组。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">如果下段食管癌且淋巴结转移≥3枚，采用单一放疗时，建议包括以下淋巴结区：104、105、106、107及腹部1、2、3、7组。如果为胸上段食管癌或上切缘≤3 cm者，建议包括</span></span><span><span leaf="">吻合口</span></span><span><span leaf="">（2B类证据）</span></span><span><span leaf="">。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf=""><br></span></span></p><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><strong><span leaf="">6</span></strong></section><section><section data-brushtype="text" hm_fix="350:507"><span leaf="">食管癌放疗剂量推荐</span></section></section></section></section></section><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><p><span><span leaf="">相对于2024版指南，2025版指南对于食管癌放疗剂量推荐有部分更新，具体如下：</span></span></p><p><span><span leaf=""><br></span></span></p><p><strong><span><span leaf="">1）新辅助放化疗：</span></span></strong><span><span leaf="">40~50.4Gy，1.8~2Gy/次，5次/周。</span></span></p><p><span><span leaf=""><br></span></span></p><p><strong><span><span leaf="">2）根治性同步放化疗：</span></span></strong><span><span leaf="">推荐剂量 50~50.4Gy，常规分割。也有需加量至 60Gy才能获益者，但需注意高剂量所致不良反应有可能会抵消获益。</span><span leaf="">颈段食管癌有可能从≥60Gy的照射剂量中获益。</span><span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0em;margin-left: 16px;outline: 0px;max-width: 100%;color: rgb(34, 34, 34);letter-spacing: 0.544px;white-space: normal;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"font-family: PingFangSC-Light;font-size: 14px;letter-spacing: 1px;color: rgb(178, 178, 178);"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><br></span></span></span></p><p><span><span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0em;margin-left: 16px;outline: 0px;max-width: 100%;color: rgb(34, 34, 34);letter-spacing: 0.544px;white-space: normal;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"font-family: PingFangSC-Light;font-size: 14px;letter-spacing: 1px;color: rgb(178, 178, 178);"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><br></span></span></span></p><p><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0em;margin-left: 16px;outline: 0px;max-width: 100%;color: rgb(34, 34, 34);letter-spacing: 0.544px;white-space: normal;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"font-family: PingFangSC-Light;font-size: 14px;letter-spacing: 1px;color: rgb(178, 178, 178);"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span textstyle="">注：相对于</span></span><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">2024版</span></span><span leaf=""><span textstyle="">指南，根治性同步放化疗中增加“</span></span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0em;margin-left: 16px;text-wrap: wrap;outline: 0px;color: rgb(34, 34, 34);letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"color: rgb(62, 62, 62);font-family: PingFangSC-Light;font-size: 14px;letter-spacing: 1px;text-wrap: wrap;background-color: rgb(255, 255, 255);"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span textstyle="">颈段食管癌有可能从≥60Gy的照射剂量中获益”</span>。</span></span></p><p><span><span leaf=""><br></span></span></p><p><strong><span><span leaf="">3）单纯放疗：</span></span></strong><span><span leaf="">60~70Gy，常规分割。</span></span></p><p><span><span leaf=""><br></span></span></p><p><strong><span><span leaf="">4）术后放疗：</span></span></strong><span><span leaf="">R1/R2术后辅助放疗 50~60Gy，常规分割。辅助同步放化疗50~50.4Gy。R0术后辅助放（化）疗 45~50.4Gy，常规分割。</span></span></p><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><strong><span leaf="">7</span></strong></section><section><section data-brushtype="text" hm_fix="350:507"><span leaf="">食管癌放疗危及器官受量推荐</span></section></section></section></section></section><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><p><span><span leaf="">食管癌放射治疗危及器官勾画主要包括</span><strong><span leaf="">脊髓、双肺、心脏、肝脏、气管、胃</span></strong><span leaf="">，其受量推荐见下图：</span></span></p><p><span><span leaf=""><br></span></span></p><section data-role="paragraph"><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><section data-tools="135编辑器" data-id="106900" data-width="100%"><section><section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd5ibbTtbNBicktkqQmZL44rG3CGLAa3KAzKZ14yibHD4hlGkNibmwlzhiaH1eiaDEbu3UsWQJTwLD6juAog/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.4638888888888889" data-s="300,640" data-type="png" data-w="1080" data-imgfileid="100053910" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd5ibbTtbNBicktkqQmZL44rG3CGLAa3KAzKZ14yibHD4hlGkNibmwlzhiaH1eiaDEbu3UsWQJTwLD6juAog/640?wx_fmt=png&amp;from=appmsg"></section><section data-autoskip="1"><p><span><span leaf="">▲食管癌放疗危及器官受量推荐</span></span></p></section></section></section></section></section></section></section></section></section><p><span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0em;margin-left: 16px;text-wrap: wrap;outline: 0px;color: rgb(34, 34, 34);letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"color: rgb(62, 62, 62);font-family: PingFangSC-Light;font-size: 14px;letter-spacing: 1px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span textstyle="">相关阅读：</span><a target="_blank" href="https://mp.weixin.qq.com/s?__biz=Mzk0MzIxOTcwMQ==&amp;mid=2247541424&amp;idx=2&amp;sn=0ded98940c869b28d7be7a779d07a9f4&amp;scene=21#wechat_redirect" textvalue="肿瘤放射治疗危及器官勾画（4讲）" data-itemshowtype="0" linktype="text" data-linktype="2"><span textstyle="">肿瘤放射治疗危及器官勾画（4讲）</span></a></span></span></p><p><span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0em;margin-left: 16px;text-wrap: wrap;outline: 0px;color: rgb(34, 34, 34);letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"color: rgb(62, 62, 62);font-family: PingFangSC-Light;font-size: 14px;letter-spacing: 1px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><br></span></span></p><p><span leaf=""><br></span></p><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><strong><span leaf="">8</span></strong></section><section><section data-brushtype="text" hm_fix="350:507"><span leaf="">食管癌放疗计划设计与优化</span></section></section></section></section></section><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><p><span><span leaf="">2025版</span><span><span leaf="">中国食管癌放射治疗指南</span></span><span leaf="">对于食管癌放疗计划设计与优化推荐与2024版一致，具体如下：</span></span></p><p><span leaf=""><br></span></p><p><span><strong><span leaf="">1. 放疗技术</span></strong></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">食管癌放疗推荐采用调强、三维适形技术：</span></span></p><p><span leaf=""><br></span></p><p><span><span leaf="">1）固定野调强建议采用6 MV X线，一般设5~7个射野，尽量避开穿射两侧肩部；2）旋转调强一般采用6 MV X线，2个弧等中心共面照射，为降低肺受量特别是低剂量照射体积，建议采用2个非全弧，即避免横向穿射肺组织；</span></span></p><p><span><span leaf="">3）螺旋断层调强可以在靶区层面通过设置屏蔽角度的方式，避免射线从肺两侧横向穿射。</span></span></p><p><span><span leaf="">4）适形放疗一般采用6~10 MV X线，以4~5野为宜，前后野权重为主以减少肺受量，侧野避开脊髓。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><strong><span><span leaf="">2. 设野方案</span></span></strong></span></p><p><span><span leaf=""><br></span></span></p><p><span><strong><span leaf="">采用适形计划射野遵循以下4个原则：</span></strong></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">1）从入射平面到靶区中心距离短；</span></span></p><p><span><span leaf="">2）避开危及器官；</span></span></p><p><span><span leaf="">3）射野边平行于靶区横断面的最长边；</span></span></p><p><span><span leaf="">4）与相邻射野夹角一般不小于40°（补量小野除外）。另外，射野等中心点一般放置在肿瘤中心处，可考虑实际照射摆位情况进行微调。</span></span></p><p><span><span leaf=""><br></span></span></p><p><strong><span><span leaf="">颈段及胸上段食管癌：</span></span></strong><span><span leaf="">颈段、胸廓入口处、胸上段食管由于其所在身体部位厚度差异大，食管位置距体表深度不一，如果解剖位置较深的靶区剂量不够，可增加1个补量小</span></span><span><span leaf="">野</span></span><span><span leaf="">，</span><span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0em;margin-left: 16px;outline: 0px;color: rgb(34, 34, 34);letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"color: rgb(62, 62, 62);font-family: PingFangSC-Light;font-size: 14px;letter-spacing: 1px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'>见下图：</span></span></span></p><p><span leaf=""><br></span></p><section data-role="paragraph"><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><section data-tools="135编辑器" data-id="106900" data-width="100%"><section><section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd5tsR4M1K26jpdmKZqhgwMfdkTMHjop8OLwBIibpdQKvaRJwialfovwQVZpBbwQgpaAiapy6cQiaRQtFQ/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.2571428571428571" data-type="png" data-w="700" data-imgfileid="100054104" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd5tsR4M1K26jpdmKZqhgwMfdkTMHjop8OLwBIibpdQKvaRJwialfovwQVZpBbwQgpaAiapy6cQiaRQtFQ/640?wx_fmt=png&amp;from=appmsg"></section><section data-autoskip="1"><p><span><span leaf="">▲颈段食管癌适形计划射野分布及BEV所示肿瘤与脊髓的相对位置 A为颈段食管癌4野共面适形照射示意图；B~E为4个照射野在BEV可见肿瘤和脊髓的相对位置，以及多叶光栅、准直器设置</span></span></p></section></section></section></section></section></section></section></section></section><p><strong><span><span leaf="">胸中、下段食管癌：</span></span></strong><span><span leaf="">分前后左右4个野或在4个野的基础上再加一个整体适形野，下图所示的前、后、左前、左后、右前5个野（其中至少有2个射野完全避开脊髓）；对于术后放疗的患者设野时应尽量避免穿过胸腔胃，如果无法避免，则应尽量减少穿过胸腔胃射野的权重，见下图：</span></span></p><p><span leaf=""><br></span></p><section data-role="paragraph"><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><section data-tools="135编辑器" data-id="106900" data-width="100%"><section><section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd5tsR4M1K26jpdmKZqhgwMfWyrVHadiaWLuETdIlXTuv2dOum86iceVtqnnHLUbpkHADI3LQ7P59N8w/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.21714285714285714" data-type="png" data-w="700" data-imgfileid="100054105" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd5tsR4M1K26jpdmKZqhgwMfWyrVHadiaWLuETdIlXTuv2dOum86iceVtqnnHLUbpkHADI3LQ7P59N8w/640?wx_fmt=png&amp;from=appmsg"></section><section data-autoskip="1"><p><span><span leaf="">▲胸段食管癌适形计划射野分布及BEV所示肿瘤与脊髓的相对位置 A为中下段食管癌5野共面适形照射示意图；B~F为5个照射野在BEV可见肿瘤和脊髓的相对位置，以及多叶光栅、准直器设置</span></span></p></section></section></section></section></section></section></section></section></section><p><strong><span><span leaf="">采用调强设野方案：</span></span></strong><span><span leaf="">颈段、胸上段食管癌推荐采用等角度分布，胸中、下段食管癌以减少肺照射体积为原则，推荐采用沿体中线两侧蝴蝶形布野，权重平均分配。</span></span></p><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><strong><span leaf="">9</span></strong></section><section><section data-brushtype="text" hm_fix="350:507"><span leaf="">特殊放疗技术的应用</span></section></section></section></section></section><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><p><span><span leaf="">放（化）疗最常见的并发症是放射性</span></span></p><p><span><span leaf=""><br></span></span></p><section><span leaf=""><span textstyle="">1. 质子、重离子放疗</span></span></section><section><span leaf=""><br></span></section><section><span leaf="">基于质子、重离子治疗食管癌缺乏高级别研究证据，目前建议有条件的中心开展相关临床研究和治疗。</span></section><section><span leaf=""><br></span></section><section><span leaf="">1）质子调强放疗技术比被动散射质子治疗能够更好地减低肺脏、心脏和肝脏受量。靶区勾画参照上述累及野相关标准要求。</span></section><section><span leaf="">2）碳离子放疗的DNA损伤率高且以双链损伤为主，对光子放疗不敏感的肿瘤具有良好的前景。需要关注其物理生物方面的不确定性。</span></section><section><span leaf=""><br></span></section><section><span leaf=""><span textstyle="">2. 后装腔内放疗</span></span></section><section><span leaf=""><br></span></section><section><span leaf="">食管癌后装腔内放疗多为外照射的一种补充，不作为常规推荐。</span></section><section><span leaf="">相关推荐：<a target="_blank" href="https://mp.weixin.qq.com/s?__biz=Mzk0MzIxOTcwMQ==&amp;mid=2247544247&amp;idx=1&amp;sn=c6b3fc05646c54db9f296605328b9ad8&amp;scene=21#wechat_redirect" textvalue="四大肿瘤近距离放疗核心技能（4讲）" data-itemshowtype="0" linktype="text" data-linktype="2">四大肿瘤近距离放疗核心技能（4讲）</a></span></section><section><span leaf=""><br></span></section><section><span leaf=""><span textstyle="">3. 放射性粒子植入</span></span></section><section><span leaf=""><br></span></section><section><span leaf="">I-125放射性粒子植入主要应用于以下两个方面：</span></section><section><span leaf=""><br></span></section><section><span leaf=""><span textstyle="">1）食管癌颈部和纵隔淋巴结转移放疗后复发的挽救性治疗：</span>建议采用治疗计划系统设计术前计划和3D打印共面或者非共面模板引导。推荐粒子活度：:0.4~0.8mCi（1mCi=37MBq）。术后应做剂量验证。</span></section><section><span leaf=""><br></span></section><section><span leaf=""><span textstyle="">2）晚期食管癌的姑息性治疗：</span>食管粒子支架是晚期食管癌的一种姑息性治疗方法，可迅速解除吞咽困难，改善生命质量，与普通支架相比能够延长食管的通畅时间，并不增加术后并发症。适用于年老体弱不适合放疗、拒绝放疗或者放疗后复发伴严重吞咽困难的晚期患者。</span></section><section><span leaf=""><br></span></section><section data-role="paragraph"><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><section data-tools="135编辑器" data-id="106900" data-width="100%"><section><section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd7RUgoBNiawXNqS1JPCu23H3AD2QvHvyPYPvLZ86cia13Isyt2DfO6XjJHiaJYMJ8ibMx2tMqxJVXhpLQ/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.6546296296296297" data-s="300,640" data-type="png" data-w="1080" type="block" data-imgfileid="100063394" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd7RUgoBNiawXNqS1JPCu23H3AD2QvHvyPYPvLZ86cia13Isyt2DfO6XjJHiaJYMJ8ibMx2tMqxJVXhpLQ/640?wx_fmt=png&amp;from=appmsg"></section><section data-autoskip="1"><p><span><span leaf="">▲食管癌特殊放疗技术的剂量推荐</span></span></p></section></section></section></section></section></section></section></section></section><p><span leaf=""><br></span></p><section data-role="title" data-tools="135编辑器" data-id="98232" data-width="94%"><section><section><section data-original-title="" title=""><strong><span leaf="">10</span></strong></section><section><section data-brushtype="text" hm_fix="350:507"><span leaf="">食管癌放化疗并发症防治</span></section></section></section></section></section><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><p><span><span leaf="">放（化）疗最常见的并发症是放射性食管炎、肺炎、心脏损伤和骨髓抑制，脊髓损伤由于精确放疗的开展而极少发生。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><strong><span><span leaf="">1. 放射性食管炎</span></span></strong></span></p><p><span><span><span leaf=""><br></span></span></span><span><span leaf="">放疗2~3周时，多数患者会出现放射性食管炎，主要表现为吞咽疼痛、进食梗阻感加重、胸骨后烧灼感或不适，严重者可出现脱水、营养不良、电解质紊乱或体重下降，少数极重者可能出现食管出血、穿孔或其他危及生命的症状，尤其是高龄、颈段或胸上段病变、接受同期化疗或加速超分割放疗者出现更早、更重。</span></span></p><p><span><span leaf=""><br></span></span></p><p><strong><span><span leaf="">治疗原则为消炎、止痛、修复受损的食管黏膜及营养支持治疗。</span></span></strong><span><span leaf="">如果不影响进食，可暂观察，进温热、无刺激的半流食，多饮水；中重度疼痛影响进食者，推荐给予静脉补液、抗炎、激素、抑酸、口服消化道黏膜保护剂如硫糖铝等处理，口服稀释后的利多卡因可达到黏膜表面麻醉效应，能减轻局部疼痛，但要注意有过敏反应者。必要时需暂停放疗。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><strong><span><span leaf="">2. 放射性肺炎</span></span></strong></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">急性放射性肺炎通常发生于放疗开始后的3个月内，主要表现为发热（多为低热）、咳嗽（多为刺激性干咳）、胸痛和呼吸困难等，严重者常因为呼吸困难而死亡，但也有一部分患者只有影像学改变而无临床症状。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">查体多无明显肺部阳性体征，部分患者可有呼吸音粗糙、呼吸音减低或干湿性啰音，但无特异性。实验室检查、肺功能检测也无特异性。胸部X线或CT检查示与照射范围一致的弥漫性片状密度增高影或条索样改变，且不按肺野或肺段等解剖结构分布。部分患者的发生部位可超出照射野外，甚至弥漫分布于双肺。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">诊断缺少特异性依据，多是根据患者接受胸部放疗后，参考正常肺组织受照体积和剂量，出现上述症状及肺部影像学改变，外周血中性粒细胞无明显升高，并排除其他原因。</span></span></p><p><span><span leaf=""><br></span></span></p><p><strong><span><span leaf="">治疗上应尽早、足量、足疗程使用糖皮质激素，临床症状明显好转后逐渐减量至停用。</span></span></strong><span><span leaf="">合并感染时，合理使用抗生素，并采用止咳祛痰、吸氧等对症处理。放射性肺炎重在预防，主要是通过精确靶区勾画和放疗计划优化尽量降低正常肺组织受照剂量和体积。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><strong><span><span leaf="">3. 放射性心脏损伤</span></span></strong></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">放射性心脏损伤是放疗后一系列心血管并发症的统称，主要包括无症状心肌缺血（隐匿性冠心病）、心律失常、心包炎、心绞痛、心肌梗死、缺血性心力衰竭，甚至猝死。潜伏期长。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">诊断主要依据是放疗后，经长时间的心血管疾病随访和心电图、心肌酶等心功能检查，超声心动图、冠脉CT、心脏微循环阻力指数（IMR）及心肌核素等影像学检查，发现冠状动脉、心肌及心包病变和心律失常等表现，并除外其他因素。</span></span></p><p><span><strong><span leaf=""><br></span></strong></span></p><p><span><strong><span leaf="">心脏受照射体积和照射剂量是最重要的影响因素</span></strong><span leaf="">，吸烟、高血压、血脂异常、肥胖、糖尿病等是高危因素，联合治疗如化疗、免疫治疗和靶向治疗等，可能会增加其发生率。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">放射性心脏损伤缺少有效、特异的治疗方案。防治原则为：</span><strong><span leaf="">减少放射性心脏损伤的危险因素，抗炎、抗血栓及营养心肌治疗。</span></strong><span leaf="">他汀类药物是目前最有效的降脂药物，还具有抗炎、抗血栓形成和抗纤维化作用，可以减轻放射诱导的心肌纤维化；血管紧张素转化酶抑制剂（ACEI）能抑制心肌纤维化，阿司匹林具有抗血小板聚集的作用，但治疗放射性心脏损伤的价值仍需进一步证实。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><strong><span><span leaf="">4. 骨髓抑制</span></span></strong></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">预防性使用粒细胞集落刺激因子（G-CSF）可降低化疗或同步放化疗后中性粒细胞减少症/伴发热（FN）及感染的风险。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">DCF方案（多西他赛+顺铂+氟尿嘧啶）的FN风险&gt;20%，需预防性使用G-CSF。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">同步放化疗期间，综合评估中性粒细胞减少症、FN及感染的风险后，推荐使用长效G-CSF。建议中性粒细胞计数&lt;2.0×109/L时，应及时给予G-CSF或长效G-CSF；血小板计数&lt;75×109/L时，应及时给予重组人白介素-11、重组人血小板生成素等相应处理。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf=""><br></span></span></p><section data-role="splitline" data-tools="135编辑器" data-id="103122"><span><span leaf="">------我是结尾分割线------</span></span></section><section><span leaf=""><br></span></section><p><span leaf=""><br></span></p><p><span><span leaf="">自2019年版发布以来，</span><span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"margin-right: 16px;margin-bottom: 0em;margin-left: 16px;outline: 0px;max-width: 100%;color: rgb(34, 34, 34);letter-spacing: 0.544px;white-space: normal;font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 2em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"color: rgb(62, 62, 62);font-family: PingFangSC-Light;font-size: 14px;letter-spacing: 1px;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'>《中国食管癌放射治疗指南》</span></span><span leaf="">每年均结合最新循证与实践进行持续更新。本指南执笔专家组组长，山东省肿瘤医院李宝生教授强调，《中国食管癌放射治疗指南》旨在紧密结合我国食管癌疾病特点和临床实践变化，为一线医生提供清晰、统一、可操作的放疗规范，推动诊疗同质化，提升整体治疗水平。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">与2024版相比，2025版指南进一步强化了放疗在食管癌多学科治疗中的核心定位，细化了不同分期、不同治疗目标下的放疗策略，在关键技术环节提出了更明确的推荐。同时，系统规范了放疗与免疫治疗的联合应用，回应临床热点，为改善患者长期预后提供了重要指导。</span></span></p><p><span><span leaf=""><br></span></span></p><p><span><span leaf="">历史文章中搜索关键词，即可进一步学习更多食管癌放射治疗基础知识和最新进展。</span></span><span><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/npJxdWx3rMpEicpDj3r9to7bUopXhU8Wno5r2ia4taICLibSMZYM5TwdwuOVffGKasTrgKichR8CUb3xtkxmdmNzBw/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-ratio="0.32592592592592595" data-s="300,640" data-type="png" data-w="1080" width="29px" data-fileid="100014488" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/npJxdWx3rMpEicpDj3r9to7bUopXhU8Wno5r2ia4taICLibSMZYM5TwdwuOVffGKasTrgKichR8CUb3xtkxmdmNzBw/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></span></span></p><p><span><span leaf=""><br></span></span></p><p><span><strong><span><span leaf="">备注</span></span></strong></span></p><p><span><span leaf="">本文旨在为医疗卫生专业人士传递更多医学信息，并不构成任何诊疗依据，内容仅供参考。</span></span></p><p><span><strong><span><span leaf="">内容来源</span></span></strong></span></p><p><span><span leaf="">中国食管癌放射治疗指南（2025年版）</span></span></p><p><span><strong><span><span leaf="">更多阅读 </span></span></strong></span><span><span leaf=""> </span></span></p><p><span><span leaf=""><a target="_blank" href="https://mp.weixin.qq.com/s?__biz=Mzk0MzIxOTcwMQ==&amp;mid=2247546793&amp;idx=1&amp;sn=8714af1cb8a08a296c49b8a82583e68f&amp;scene=21#wechat_redirect" textvalue="2025年终盘点 | 聚焦新辅助免疫联合放化疗，食管癌放射治疗领域重要进展" data-itemshowtype="0" linktype="text" data-linktype="2"><span textstyle="">2025年终盘点 | 聚焦新辅助免疫联合放化疗，食管癌放射治疗领域重要进展</span></a></span></span></p><p><span><span leaf=""><a target="_blank" href="https://mp.weixin.qq.com/s?__biz=Mzk0MzIxOTcwMQ==&amp;mid=2247546459&amp;idx=2&amp;sn=188641c1f4c125769fcc7f0ee6bf69ff&amp;scene=21#wechat_redirect" textvalue="不可手术食管癌放疗靶区勾画与计划设计" data-itemshowtype="0" linktype="text" data-linktype="2"><span textstyle="">不可手术食管癌放疗靶区勾画与计划设计</span></a></span></span></p><p><span><span leaf=""><a target="_blank" href="https://mp.weixin.qq.com/s?__biz=Mzk0MzIxOTcwMQ==&amp;mid=2247546973&amp;idx=1&amp;sn=033bdd5ef501b898d0174e2bafcd007b&amp;scene=21#wechat_redirect" textvalue="练习题库：放射肿瘤治疗学（正/副高）| 2026年卫生高级职称考试" data-itemshowtype="0" linktype="text" data-linktype="2"><span textstyle="">练习题库：放射肿瘤治疗学（正/副高）| 2026年卫生高级职称考试</span></a></span></span></p><p><span><span leaf=""><a target="_blank" href="https://mp.weixin.qq.com/s?__biz=Mzk0MzIxOTcwMQ==&amp;mid=2247546793&amp;idx=2&amp;sn=6dd09f7b1333b9f9b9514fc113caff1b&amp;scene=21#wechat_redirect" textvalue="4天实战培训，用AI重构你的SCI写作思维与流程 | 1月29日~2月1日" data-itemshowtype="0" linktype="text" data-linktype="2"><span textstyle="">4天实战培训，用AI重构你的SCI写作思维与流程 | 1月29日~2月1日</span></a></span></span></p><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><section data-tools="135编辑器" data-id="96316"><section data-role="paragraph"><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_gif/mRTYBJwUvQrWWY8adrMI9oYDk90T6k7672iaU2VlGP93LZLKdsuDR8txHrgpmYnY5I0lGNgxe4krON06BV8micWA/640?wx_fmt=gif&amp;wxfrom=5&amp;wx_lazy=1&amp;tp=webp" alt="图片" data-ratio="1" data-type="gif" data-w="300" data-fileid="100014425" data-imgfileid="100054107" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_gif/mRTYBJwUvQrWWY8adrMI9oYDk90T6k7672iaU2VlGP93LZLKdsuDR8txHrgpmYnY5I0lGNgxe4krON06BV8micWA/640?wx_fmt=gif&amp;wxfrom=5&amp;wx_lazy=1&amp;tp=webp"></section></section><section data-role="paragraph"><section><span leaf=""><br></span></section><p><span leaf=""><br></span></p><p><span leaf=""><br></span></p><hr><p><span leaf=""><br></span></p><section><span><span leaf="">星标关注「放疗说」微信公众号</span></span></section><section><span><span leaf="">精彩内容永不错过</span></span></section><section nodeleaf=""><mp-common-profile data-pluginname="mpprofile" data-nickname="放疗说" data-alias="fangliaoshuo" data-index="0" data-from="2" data-headimg="http://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd4GP3UUlHS5gRBZJsf0PVFmkHia1P20bUdLvAwuyg4AL1M5WlbVwqNs7RXicpFXv56zRhadLmaTtb7g/300?wx_fmt=png&amp;wxfrom=19" data-signature="专业科普，学术交流，记录不断进步的放疗行业。官方合作请联系：fangliaoshuo@qq.com" data-id="Mzk0MzIxOTcwMQ==" data-is_biz_ban="0" data-origin_num="810" data-biz_account_status="0"></mp-common-profile></section></section><section data-role="paragraph"><section data-role="paragraph"><section data-tools="135编辑器" data-id="103131"><section><section><section><span leaf=""><br></span></section><section data-brushtype="text"><span><strong><span leaf="">|推|荐|</span></strong></span></section><section><span leaf=""><br></span></section></section><section data-width="100%"><span leaf=""><br></span></section></section></section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd6ibW0xcJ1L3XnO1haIqKReqgVNGcQ2kM1ubN9Gk9onibWp6DTqAqCo8LbaswMib2jPWwiaZS9cnj5SSg/640?wx_fmt=other&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" alt="图片" data-ratio="0.5555555555555556" data-type="pngwxfrom=5wx_lazy=1wx_co=1" data-w="1080" data-cropselx1="0" data-cropselx2="578" data-cropsely1="0" data-cropsely2="326" data-fileid="100014426" data-imgfileid="100054109" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/vsPMeLGfrd6ibW0xcJ1L3XnO1haIqKReqgVNGcQ2kM1ubN9Gk9onibWp6DTqAqCo8LbaswMib2jPWwiaZS9cnj5SSg/640?wx_fmt=other&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section><section data-role="splitline" data-tools="135编辑器" data-id="103115" data-width="100%"><section><section><section><span leaf=""><br></span></section><section><span leaf=""><br></span></section><section><span leaf=""><br></span></section><section><span leaf=""><br></span></section><section><span leaf=""><br></span></section><section><span leaf=""><br></span></section></section></section></section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/vsPMeLGfrd774hRibPp7HtP6sdpIv6kzrB4evrOUiaKEtcwTYgFR1tNmn1GjnaCZR95xuULiaKp5xuibhavlJ4bLXQ/640?wx_fmt=jpeg&amp;from=appmsg" data-ratio="0.55546875" data-s="300,640" data-type="jpeg" data-w="1280" data-croporisrc="https://mmbiz.qpic.cn/mmbiz_jpg/vsPMeLGfrd774hRibPp7HtP6sdpIv6kzrB4evrOUiaKEtcwTYgFR1tNmn1GjnaCZR95xuULiaKp5xuibhavlJ4bLXQ/0?wx_fmt=jpeg&amp;from=appmsg" data-cropselx2="578" data-cropsely2="322" data-imgfileid="100062676" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_jpg/vsPMeLGfrd774hRibPp7HtP6sdpIv6kzrB4evrOUiaKEtcwTYgFR1tNmn1GjnaCZR95xuULiaKp5xuibhavlJ4bLXQ/640?wx_fmt=jpeg&amp;from=appmsg"></section><p><span leaf=""><br></span></p><section data-role="paragraph"><section data-width="100%"><section><section data-brushtype="text" fix="191:485" hm="" data-lazy-bgimg="https://mmbiz.qpic.cn/mmbiz_png/npJxdWx3rMrXpsTZoibezibA6INKaaJqD8V1wh4NVtO3KN5uicy6SvhOlUsyeibSjCDzd23H5nDkg4kmZaicItPJebw/640?wx_fmt=png" data-fail="0"><span><span leaf="">点击阅读原文，发现</span></span><span><span leaf="">放疗学园</span></span></section></section></section></section></section></section></section><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/yOxrw6T5dBvsVXyeDMC3cg",target="_blank" rel="noopener noreferrer">原文链接</a>
